End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.35 CNY | -18.75% |
|
-.--% | -45.40% |
07-01 | Hainan Poly Pharm's Gets Certification for Invasive Aspergillosis Drug | MT |
06-25 | Hainan Poly Pharm Gets Nod to Market Voriconazole Injection in Denmark | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.40% | 762M | |
+54.07% | 809B | |
+38.95% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.21% | 238B | |
-0.45% | 221B | |
+14.58% | 218B | |
+7.42% | 166B |
- Stock Market
- Equities
- 300630 Stock
- News Hainan Poly Pharm. Co., Ltd
- Hainan Poly Pharm Gets Regulatory OK to Convert Desloratadine Dispersible Tablets into Over-The-Counter Drugs